semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42497473
Effects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis.
Effects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis.
- 저자
- Milene Vitória Sampaio Sobral, Rodrigo Bettanim Menechini, Jordana Belgamasco Cavalcanti Marçal, Anna Victoria de Vasconcelos, Letícia Hanna Moura da Silva Gattas Graciolli, Rafaela Correia Maciel
- 저널
- Schizophrenia research
- 공개일
- 2026 Jul 24
- 연구 유형
- 기타
- DOI
- 10.1016/j.schres.2026.06.025
문헌 요약
Individuals with schizophrenia have markedly increased cardiometabolic morbidity, largely attributable to antipsychotic-induced weight gain, insulin resistance, and dyslipidemia, particularly with clozapine- and olanzapine-based regimens. This systematic review and meta-analysis evaluated the efficacy and safety of glucagon-like peptide-1 receptor agonist…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.